Cataract is the presence of opacity in the crystalline lens of the eye. It causes painless, progressive blurring of vision.
It is the leading cause of blindness worldwide and the most prevalent ocular disease.
The initiating events that lead to loss of transparency of both the cortical and nuclear lens tissue is the oxidation of the membrane lipids, structural or enzymatic proteins or DNA by peroxidases or free radicals induced by UV light.
Cataract is the presence of opacity in the crystalline lens that causes painless, progressive blurring of vision
Leading cause of blindness worldwide & the most prevalent ocular disease
Mechanism of cataract formation is multifactorial
Chronic & age-related
Signs and Symptoms
Decreased vision & increased problems w/ glare are the hallmark symptoms
Increased nearsightedness called “myopic shift “before opacity of the lens occur
Typically bilateral but often asymmetrical
Initiating events that lead to loss of transparency of both the cortical & nuclear lens tissue is the oxidation of the membrane lipids, structural or enzymatic proteins or DNA by peroxidases or free radicals induced by ultraviolet (UV) light
Ultraviolet (UV) radiation - ultraviolet B (UVB) cumulative lifetime exposure
Diabetes mellitus, hypertension, high body mass index
Drugs (eg long-term topical, systemic or inhaled corticosteroids, Phenothiazine, Chlorpromazine)
Drinking excessive amounts of alcohol
Gender - females are most likely to have cataract & progress to blindness
Nutrition - low antioxidant levels is associated w/ increased risk of cataract formation
Routinely used for treating cardiovascular diseases, statins have been shown to benefit other conditions, and new evidence suggests that using the drug at high intensity reduces the risk of hip or knee replacement, an effect that may be specific to rheumatoid arthritis.
Having migraine during midlife appears to be associated with a higher risk of developing dementia in later life, according to a large population-based longitudinal Danish study presented at the AHS* 2020 Virtual Meeting, indicating that migraine may be a risk factor for dementia.
Pembrolizumab in combination with chemotherapy significantly improves progression-free survival (PFS) vs chemotherapy alone in patients with previously untreated, locally recurrent inoperable or metastatic triple-negative breast cancer (TNBC), results of the KEYNOTE-355 study have shown.